Who
Brian Guan-Chyun Liu
Director
Company insider
Files Form 4 as: Director, CG Oncology.
In numbers
- Trades disclosed
- 7
- Buys
- 2
- Sells
- 0
- Bought
- $99.6M
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 1
- First trade
- 4 Oct 2024
- Last trade
- 25 Jun 2026
- Last filed
- 29 Jun 2026
Companies traded
Activity over time
1 Sep 2025 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 25 Jun 2026filed 29 Jun 2026 | CGON CG OncologyBiotechnology | SEC FORM 4 Bought | $24.8M371,085 at $66.87 | filing |
| 25 Jun 2026filed 29 Jun 2026 | CGON CG OncologyBiotechnology | SEC FORM 4 Bought | $24.8M371,085 at $66.87 | filing |
| 4 Jun 2026filed 5 Jun 2026 | CGON CG Oncologyoption or derivative · Biotechnology | SEC FORM 4 Code A | —9,354 at $0.00 | filing |
| 4 Jun 2026filed 5 Jun 2026 | CGON CG Oncologyoption or derivative · Biotechnology | SEC FORM 4 Code A | —9,354 at $0.00 | filing |
| 11 Sep 2025filed 15 Sep 2025 | CGON CG OncologyBiotechnology | SEC FORM 4 Bought | $50.0M1,515,151 at $33.00 | filing |
| 5 Jun 2025filed 6 Jun 2025 | CGON CG Oncologyoption or derivative · Biotechnology | SEC FORM 4 Code A | —24,165 at $0.00 | filing |
| 4 Oct 2024filed 7 Oct 2024 | CGON CG Oncologyoption or derivative · Biotechnology | SEC FORM 4 Code A | —15,600 at $0.00 | filing |
News
Head to Head Contrast: CG Oncology (NASDAQ:CGON) and Myriad Genetics (NASDAQ:MYGN)CGON · tickerreport.com · 8 Oct 2026
0 headlines in the last 90 days name Brian Guan-Chyun Liu; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.